Grannus Therapeutics is a biotechnology company that focuses on the development of small-molecule inhibitors for specific isoforms of HSP90. The company was founded in 2020 and is headquartered in Indianapolis, Indiana.
Partial Data by Infogroup (c) 2024. All rights reserved.